Balance Sheet
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Others
Ratios

Armata Pharmaceuticals, Inc. (ARMP) Equity Average (2016 - 2018)

Armata Pharmaceuticals' Equity Average history spans 5 years, with the latest figure at $10.2 million for Q3 2018.

  • For Q3 2018, Equity Average rose 3.76% year-over-year to $10.2 million; the TTM value through Sep 2018 reached $10.2 million, up 3.76%, while the annual FY2017 figure was $17.0 million, N/A changed from the prior year.
  • Equity Average for Q3 2018 was $10.2 million at Armata Pharmaceuticals, down from $13.1 million in the prior quarter.
  • Across five years, Equity Average topped out at $19.9 million in Q3 2016 and bottomed at -$28.3 million in Q1 2014.
  • The 5-year median for Equity Average is $10.0 million (2017), against an average of $6.1 million.
  • The largest annual shift saw Equity Average soared 6703.32% in 2016 before it plummeted 50.6% in 2017.
  • A 5-year view of Equity Average shows it stood at $3.9 million in 2014, then surged by 268.37% to $14.4 million in 2015, then decreased by 2.78% to $14.0 million in 2016, then increased by 22.0% to $17.0 million in 2017, then crashed by 40.31% to $10.2 million in 2018.
  • Per Business Quant, the three most recent readings for ARMP's Equity Average are $10.2 million (Q3 2018), $13.1 million (Q2 2018), and $19.5 million (Q1 2018).